Varex Imaging Co. (NASDAQ:VREX – Get Free Report) CEO Sunny Sanyal sold 8,749 shares of the firm’s stock in a transaction that occurred on Wednesday, April 2nd. The shares were sold at an average price of $11.24, for a total transaction of $98,338.76. Following the completion of the sale, the chief executive officer now directly owns 190,193 shares of the company’s stock, valued at approximately $2,137,769.32. This represents a 4.40 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.
Varex Imaging Stock Performance
Shares of Varex Imaging stock opened at $8.28 on Friday. Varex Imaging Co. has a 52 week low of $7.77 and a 52 week high of $18.17. The company has a debt-to-equity ratio of 1.02, a quick ratio of 2.50 and a current ratio of 4.36. The stock has a market capitalization of $341.14 million, a price-to-earnings ratio of -7.08 and a beta of 0.65. The firm has a fifty day moving average of $12.80 and a two-hundred day moving average of $13.40.
Varex Imaging (NASDAQ:VREX – Get Free Report) last released its earnings results on Thursday, February 6th. The company reported $0.07 earnings per share for the quarter, beating the consensus estimate of $0.04 by $0.03. Varex Imaging had a positive return on equity of 4.00% and a negative net margin of 5.79%. As a group, equities research analysts predict that Varex Imaging Co. will post 0.53 EPS for the current year.
Institutional Inflows and Outflows
Analyst Upgrades and Downgrades
A number of research analysts have commented on the company. B. Riley reiterated a “buy” rating and issued a $22.00 price objective (up from $21.00) on shares of Varex Imaging in a research report on Friday, February 7th. StockNews.com upgraded Varex Imaging from a “hold” rating to a “buy” rating in a research report on Friday, February 7th. Finally, Oppenheimer cut their target price on shares of Varex Imaging from $30.00 to $23.00 and set an “outperform” rating on the stock in a research report on Friday, February 7th.
Read Our Latest Report on VREX
About Varex Imaging
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.
Featured Stories
- Five stocks we like better than Varex Imaging
- Buy P&G Now, Before It Sets A New All-Time High
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- High Flyers: 3 Natural Gas Stocks for March 2022
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Receive News & Ratings for Varex Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varex Imaging and related companies with MarketBeat.com's FREE daily email newsletter.